Medical Device News Magazine

Steve Wubker New CEO of Mellitus Health

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Steve Wubker is the new CEO of Mellitus Health effective July 27, 2020.

Steve Wubker brings decades of expertise to Mellitus Health. After a 15-year career in medical sales and medical sales management, in 2000 Steve became President and CEO of Transaction Data Systems (TDS), where he took its Rx30 Pharmacy software platform from roughly 800 pharmacies to an industry-leading 8,500 pharmacies.

“I am very excited to join the Mellitus Health team of professionals,” Steve said. “The opportunity to improve patient health outcomes through advanced software for diabetes control offers many parallels that drove our business at TDS—improved patient health, operational efficiencies, cost-effectiveness, and a tool that truly provides an invaluable asset for all parties involved. I see opportunities and challenges that remind me of when I first started at TDS, and I’m excited to start this familiar journey again with such a talented group of people. Knowing how dangerous and debilitating diabetes can be, I can’t wait to see the positive difference our team at Mellitus Health can make in the fight against diabetes.”

Steve has served as President of the American Pharmacy Alliance and Vice President of the American Society for the Automation of Pharmacy, and he has served on the advisory boards of RelayHealth, Change Healthcare, and Wolters Kluwer. He has also been a member of the National Community Pharmacy Association and the National Council for Prescription Drug Programs.

“Everyone at Mellitus Health is looking forward to the impact Steve’s proven leadership, pharmacy industry and sales experience, and vision will have on our company’s future,” said Josh Davidson, who has served as CEO of Mellitus Health since its founding, and will continue to serve in a leadership role as Chief Product Officer. “Our small team has accomplished a lot, and now we’ve come to this moment of opportunity. Steve has been here before, and he sees our technology’s enormous potential for improving diabetes care, especially now that pharmacy-based care and remote patient monitoring are more important than ever. He’s exactly the CEO we’ve been looking for to guide Mellitus Health through this exciting next chapter of our growth.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”